February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing the release of their second industry framework for the use of consumer cardiovascular technology solutions in the screening and diagnosis for cardiovascular conditions.  This new document builds off of the previously published 

February 7, 2024 — Researchers presenting preliminary late-breaking science presented on the first day of the American Stroke Association’s International Stroke Conference, ISC 2024, reported findings from the highly-anticipated

February 7, 2024 — Eleven scientists leading the way in stroke research will be recognized during the American Stroke Association’s International Stroke Conference 2024, ISC24, for their exceptional professional achievements.

February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s New Drug Application (NDA) for 

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. 

February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, revealed findings from a company-funded study of real-world data.

February 2, 2024 — The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held in person at the Heart House in Washington, D.C., from Feb. 9-11, 2024, with program planners preparing a robust program.

February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now